Literature DB >> 3162022

OKT4:OKT8 ratios of circulating T cells and in vitro suppressor cell function of patients with juvenile rheumatoid arthritis (JRA).

K Oen, J A Wilkins, D Krzekotowska.   

Abstract

OKT4:OKT8 ratios of circulating T cells and in vitro suppressor cell function of patients with juvenile rheumatoid arthritis (JRA) were studied and correlations were made with clinical characteristics and laboratory variables of disease activity. Suppression of pokeweed mitogen induced immunoglobulin synthesis by OKT4+ and OKT8+ cells was taken as a measure of suppressor cell function. Mean values of OKT4:OKT8 ratios were increased in patients with JRA. A decrease in suppressor cell function correlated with high OKT4:OKT8 ratios but neither abnormality was related to increased disease activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3162022

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Activation of OKT4 suppressor cells in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis.

Authors:  K Oen; D Krzekotowska
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

2.  Pokeweed mitogen and Staphylococcus aureus Cowan I induced immunoglobulin A synthesis by lymphocytes of IgA deficient blood donors.

Authors:  K Oen; M L Schroeder; D Krzekotowska
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

3.  Immunoglobulin and cytokine production by neonatal lymphocytes.

Authors:  W Watson; K Oen; R Ramdahin; C Harman
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

4.  Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Clinical and laboratory correlations.

Authors:  K Müller; F K Pedersen; A Wiik; K Bendtzen
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

5.  Phenotypes of peripheral blood T lymphocytes in rheumatoid arthritis and juvenile rheumatoid arthritis. Findings in patients with varying disease activity and clinical subgroups.

Authors:  J Thoen; O Førre
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.